Welcome to our dedicated page for Redwire Corporation news (Ticker: RDW), a resource for investors and traders seeking the latest updates and insights on Redwire Corporation stock.
Redwire Corporation (RDW) delivers mission-critical space infrastructure solutions through its unique blend of aerospace heritage and technological innovation. This dedicated news hub provides investors and industry professionals with essential updates on the company's strategic developments in the evolving space economy.
Access authoritative reporting on Redwire's operational milestones including contract awards, R&D breakthroughs, and partnership announcements. Our curated collection features official press releases and verified news covering satellite component innovations, in-space propulsion advancements, and government contract updates.
Key focus areas include systems integration achievements, space manufacturing developments, and leadership in sustainable orbital infrastructure. Stay informed about RDW's position in critical markets through comprehensive coverage of earnings announcements, strategic collaborations, and technology transfer initiatives.
Bookmark this page for streamlined access to Redwire's latest business developments. Regularly updated content ensures you maintain current awareness of this aerospace innovator's progress in advancing space exploration capabilities.
Redwire Corporation (NYSE:RDW) announced that its Chief Scientist, Dr. Kenneth Savin, has been named to TIME100 Health's 2025 list of most influential people in global health. Dr. Savin was recognized for his pioneering work in space biotech research, including groundbreaking achievements like bioprinting the first human knee meniscus and cardiac tissue on the International Space Station (ISS). His work at Redwire includes coordinating protein crystallization investigations with pharmaceutical companies like Eli Lilly and Bristol Myers Squibb using Redwire's PIL-BOX lab, focusing on drug development for various conditions including antiviral, antifungal, and antiseizure applications.
Prior to Redwire, Dr. Savin spent 20 years at Eli Lilly leading R&D teams and conducting ISS investigations, followed by a role as Senior Director at the ISS National Lab where he developed the In Space Production and Applications program.
Redwire Corporation (NYSE: RDW) has scheduled its first quarter 2025 financial results announcement for May 12, 2025, before market open. The company will host a conference call at 9 a.m. EDT the same day to discuss the Q1 2025 results.
The earnings call will be accessible via phone (toll-free: 877-485-3108 or toll: 201-689-8264) using conference ID 13753501. A live webcast with slides will be available through the company's investor relations website. For those unable to attend live, a replay will be available for two weeks following the event.
Redwire (NYSE: RDW) has expanded its in-space pharmaceutical program with the launch of new drug development technology and a cancer-detection experiment to the International Space Station (ISS). The company introduced a high-volume Industrial Crystallizer capable of processing samples up to 200x the volume of the original PIL-BOX technology.
The groundbreaking 'Golden Balls' experiment aims to produce gold nanospheres in space for the first time. These nanospheres could enhance cancer detection, targeted drug delivery, and therapy treatments. According to John Vellinger, Redwire's President of In-Space Industries, space-produced golden nanospheres are expected to have tighter size distributions and larger dimensions while maintaining surface structure quality.
The Industrial Crystallizer and Golden Balls experiment were launched aboard SpaceX's 32nd commercial resupply mission to the ISS on April 21st.
Redwire (NYSE:RDW) has secured a contract from Thales Alenia Space to provide docking systems for the European Space Agency's lunar Gateway habitation module (Lunar I-Hab). The contract includes four International Berthing and Docking Mechanisms (IBDM): one active system to connect Lunar I-Hab to the Gateway and three passive systems for other modules or visiting vehicles.
The IBDM systems, to be delivered by Redwire's Belgian subsidiary Redwire Space NV, will facilitate safe crew and cargo transfers, featuring advanced automation, precision alignment, and multiple redundancies. The Lunar I-Hab module, constructed under Thales Alenia Space's leadership, will provide living quarters, laboratory space, and mission support infrastructure for astronauts during extended deep space missions.
Redwire (NYSE: RDW) and ispace technologies-U.S. have signed a memorandum of understanding to collaborate on commercial lunar exploration and science missions. The partnership will focus on NASA's Commercial Lunar Payload Services (CLPS) initiative and other customers.
The collaboration leverages ispace's APEX lunar lander technology, which builds upon their Hakuto-R lunar exploration program experience. The APEX lander is designed as a multi-purpose platform for delivering payloads to lunar surface or orbit.
The partnership combines Redwire's expertise in digital engineering, integration, testing, and lunar subsystems with ispace's proven lunar landing platform. This initiative falls under NASA's CLPS program, which has a maximum contract value of $2.6 billion through 2028. Redwire is one of 14 prime contractors on the CLPS IDIQ contract.
Redwire (NYSE: RDW) has appointed Mike Gold as President of Civil and International Space business to spearhead the company's global expansion initiatives. The appointment aligns with Redwire's recent European expansion, including a new office in Warsaw, Poland.
The strategic move comes as institutional space budgets worldwide reach record highs and the European Space Agency (ESA) focuses on sustainable growth in the European space sector. Redwire's established international presence, demonstrated through successful Proba satellites and European programs, positions the company favorably for global market expansion under Gold's leadership.
Redwire (NYSE: RDW) has completed the redemption of its outstanding public warrants. The company announced that warrants remaining unexercised by March 24, 2025, would be redeemed at $0.01 per warrant.
Prior to the redemption date, 7,205,399 warrants were exercised at $11.50 each, generating approximately $82.9 million for Redwire's balance sheet. The remaining 1,450,586 unexercised warrants were redeemed for approximately $14.5 thousand.
Following the redemption, Redwire has no warrants outstanding and 77,082,332 shares of common stock outstanding. The warrants have ceased trading and were delisted from the NYSE, while the common stock continues trading under the symbol 'RDW'.
Redwire (NYSE: RDW) has secured a NASA contract to conduct four additional pharmaceutical drug investigations on the International Space Station using their Pharmaceutical In-space Laboratory (PIL-BOX). The NASA-funded research aims to manufacture high-value seed crystals that could enhance pharmaceutical manufacturing in space stations.
The company's PIL-BOX platform has already processed 28 units, offering pharmaceutical researchers unique opportunities to grow small-batch crystals of protein-based pharmaceuticals in microgravity. Previous research suggests that space-grown crystals may be more uniform with fewer imperfections, potentially improving drug discovery and development processes. Past investigations have focused on advancing treatments for cardiovascular disease, obesity, and diabetes.
Redwire (NYSE: RDW) has announced receiving all necessary regulatory approvals for its planned acquisition of Edge Autonomy. The approvals include completion of antitrust review under the Hart-Scott-Rodino Act in the United States, along with foreign investment reviews in Latvia, Canada, and the United Kingdom.
The transaction is expected to close in the second quarter of 2025, pending final closing conditions and Redwire stockholder approval. The company will file a proxy statement with the SEC regarding a special meeting of stockholders to vote on the acquisition.
The merger represents a strategic move in the space infrastructure sector, though it faces various risk factors including integration challenges, market uncertainties, and potential dilution for existing stockholders due to additional share issuance for the acquisition.
Redwire (NYSE: RDW), a leader in space infrastructure for the next generation space economy, has announced its participation in the upcoming 37th Annual Roth Conference. Chief Financial Officer Jonathan Baliff will deliver a presentation on March 18, 2025, scheduled from 10:30-10:55 a.m. PT.
The presentation will be accessible to viewers through a dedicated web platform at https://event.summitcast.com/view/YsA9Ty4sRyad4m3F6KNZ7x/guest_book?session_id=EPYpaTTdvqMXn2D7k3q5hc